20
KIT
Kit that's coming soon
Sigi insulin pump
In November 2021, AMF Medical announced that its
Sigi Insulin Management System, for treating Type 1
diabetes, has met the criteria and has been granted
Breakthrough Device Designation by the US Food and
Drug Administration. (FDA).
Originally founded in 2014 in the Swiss Medtech
Valley, AMF Medical is developing a novel technology
to address the unmet needs of people on insulin
therapy. The company's flagship product, Sigi, is a nextgeneration,
plug'n go, semi-reusable and rechargeable
patch pump, designed to make life easier for people living
with diabetes.
"Clinical study data has shown that Sigi is easy to use.
Study patients expressed satisfaction as well as eagerness
for this next-generation patch to be readily available," said
Professor Anne Wojtusciszyn, MD, PhD from Lausanne
University Hospital (CHUV) and principal investigator of
the first Sigi clinical study.
Sigi can be programmed to deliver basal and bolus
insulin at both set and variable rates. In addition, as
an Alternate Controller Enabled-pump (ACE), it is able
to receive, execute and confirm dosing commands by
interacting with Bluetooth-compatible, continuous
glucose monitors and alternate controller devices, like a
smartphone or an iController.
Sigi is also smaller, lighter and more convenient than
other current insulin delivery systems. This is made
possible by its ergonomic design, which accommodates
standard pre-filled insulin cartridges.
Sigi is intended for prescription-use only and is not
yet CE-marked.
To watch a video about Sigi technology, CLICK HERE.
www.sigipump.com
Sigi Pump from AMF Medical 3 pump/pad connection. Sigi Pump AMF Medical USB charger.
Sigi Pump from AMF Medical 2 pump, cap, cartridge. Sigi Pump from AMF Medical 4 applicator.